Table 2.
FA value | ADC value (10−3MM2/S) | |||
---|---|---|---|---|
Corpus callosum | Eyeborg user | 0.57 ± 0.02* | 0.92 ± 0.03 | |
Controls | 0.52 ± 0.03 | 0.88 ± 0.02 | ||
Inferior longitudinal fasciculus | ||||
Left | Eyeborg user | 0.53 ± 0.01 | 0.85 ± 0.02 | |
Controls | 0.49 ± 0.03 | 0.84 ± 0.04 | ||
Right | Eyeborg user | 0.51 ± 0.01 | 0.86 ± 0.02 | |
Controls | 0.48 ± 0.02 | 0.82 ± 0.04 | ||
Inferior fronto-occipital fasciculus | ||||
Left | Eyeborg user | 0.51 ± 0.06 | 0.82 ± 0.02 | |
Controls | 0.45 ± 0.08 | 0.85 ± 0.09 | ||
Right | Eyeborg user | 0.50 ± 0.07 | 0.83 ± 0.01 | |
Controls | 0.48 ± 0.01 | 0.89 ± 0.02 |
FA = fractional anisotropy value; ADC = apparent diffusion coefficient; *p < 0.05. Diffusion Tensor Imaging results for white selected white matter tracts in the Eyeborg user and controls.